Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans

Journal of Medical Microbiology

Volumn 58, Issue 8, 2009, Pages 1074-1079

  Guo, Na ^a   Liu, Jingbo ^a   Wu, Xiuping ^a   Bi, Xingming ^a   Meng, Rizeng ^b   Wang, Xuelin ^a   Xiang, Hua ^a   Deng, Xuming ^a   Yu, Lu ^a  

^a JILIN UNIVERSITY   (China)

^b Jilin Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; THYMOL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DILUTION; DRUG EFFICACY; DRUG POTENTIATION; FUNGAL STRAIN; FUNGUS ISOLATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; THYMOL;

EID: 67650738962     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.008052-0     Document Type: Article

References (24)

1. Anttila, V. J., Ruutu, P., Bondestam, S., Jansson, S. E., Nordling, S., Färkkilä, M., Sivonen, A., Castren, M. & Ruutu, T. (1994). Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 18, 979-981. (Pubitemid 24171347)
2. Burt, S. A., van der Zee, R., Koets, A. P., de Graaff, A.M., van Knapen, F., Gaastra, W., Haagsman, H. P. & Veldhuizen, E. J. (2007). Carvacrol induces heat shock protein 60 and inhibits synthesis of flagellin in Escherichia coli O157 :H7. Appl Environ Microbiol 73, 4484-4490. (Pubitemid 47122592)
3. Deng, X. L., Zhang, X. C., Zhang, F., Li, R. Y., Lu, H. J., He, W. Q., Liu, L. G., Fan, B. & Hu, X. Y. (2006). Cloning and sequencing of the GTP cyclohydrolase I function region of azole target enzyme gene in artificially induced resistant Candida albicans. Beijing Da Xue Xue Bao 38, 301-304.
4. Didry, N., Dubreuil, L. & Pinkas, M. (1994). Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria. Pharm Acta Helv 69, 25-28. (Pubitemid 24246737)
5. Giordani, R., Regli, P., Kaloustian, J., Mikaïl, C., Abou, L. & Portugal, H. (2004). Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris. Phytother Res 18, 990-995.
6. Greco, W. R., Bravo, G. & Parsons, J. C. (1995). The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47, 331-385.
7. Guo, Q., Sun, S., Yu, J., Li, Y. & Cao, L. (2008). Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol 57, 457-462.
8. He, L., Mo, H., Hadisusilo, S., Qureshi, A. A. & Elson, C. E. (1997). Elson isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127, 668-674. (Pubitemid 27200738)
9. Healing, T. D. & Oppenheim, B. A. (1990). Silver nitrate and thymol; two disinfectants effective against Legionella pneumophila. J Hosp Infect 15, 395-396. (Pubitemid 20299190)
10. Koşar, M., Demirci, B., Demirci, F. & Başer, K. H. (2008). Effect of maturation on the composition and biological activity of the essential oil of a commercially important Satureja species from Turkey: Satureja cuneifolia Ten. (Lamiaceae). J Agric Food Chem 56, 2260-2265.
11. Marchetti, O., Moreillon, P., Entenza, J. M., Vouillamoz, J., Glauser, M. P., Bille, J. & Sanglard, D. (2003). Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother 47, 1565-1570. (Pubitemid 36548538)
12. NCCLS (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, vol.17, no.9, approved standard M27-A. Wayne, PA: National Committee for Clinical and Laboratory Standards.
13. Ogaard, B., Larsson, E., Glans, R., Henriksson, T. & Birkhed, D. (1997). Antimicrobial effect of a chlorhexidine-thymol varnish (cervitec) in orthodontic patients. A prospective, randomized clinical trial. J Orofac Orthop 58, 206-213.
14. Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Jr, Calandra, T. F., Edwards, J. E., Jr, Filler, S. G., Fisher, J. F., Kullberg, B.-J. & other authors (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48, 503-535.
15. Prichard, M. N., Prichard, L. E. & Shipman, C., Jr (1993). Strategic design and three-dimensional analysis of antiviral drug combinations. Antimicrob Agents Chemother 37, 540-545. (Pubitemid 23072600)
16. Quan, H., Cao, Y. Y., Xu, Z., Zhao, J. X., Gao, P. H., Qin, X. F. & Jiang, Y. Y. (2006). Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother 50, 1096-1099. (Pubitemid 43327820)
17. Sanglard, D., Ischer, F., Parkinson, T., Falconer, D. & Bille, J. (2003). Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47, 2404-2412. (Pubitemid 36919437)
18. Shin, S. & Kim, J. H. (2004). Antifungal activities of essential oils from Thymus quinquecostatus and T. magnus. Planta Med 70, 1090-1092. (Pubitemid 39587047)
19. Sun, S., Li, Y., Guo, Q., Shi, C., Yu, J. & Ma, L. (2008). In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Chemother 52, 409-417.
20. Tariq, V. N., Scott, E. M. & McCain, N. E. (1995). Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Chemother 39, 2615-2619.
21. Uppuluri, P., Nett, J., Heitman, J. & Andes, D. (2008). Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52, 1127-1132. (Pubitemid 351358397)
22. Vanden Bossche, H. (1985). Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. Curr Top Med Mycol 1, 313-351.
23. Viollon, C. & Chaumont, J. P. (1994). Antifungal properties of essential oils and their main components upon Cryptococcus neoformans. Mycopathologia 128, 151-153.
24. White, T. C., Holleman, S., Dy, F., Mirels, L. F. & Stevens, D. A. (2002). Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46, 1704-1713. (Pubitemid 34535186)